All Stories

  1. Suicide-Gene-Modified Extracellular Vesicles of Human Primary Uveal Melanoma in Future Therapies

    Article • International Journal of Molecular Sciences, August 2023, MDPI AG

    Cestmir Altaner

  2. Extracellular vesicles derived from dental mesenchymal stem/stromal cells with gemcitabine as a cargo have an inhibitory effect on the growth of pancreatic carcinoma cell lines in vitro

    Article • Molecular and Cellular Probes, February 2023, Elsevier

    Cestmir Altaner

  3. Tumor-targeted suicide gene-directed enzyme prodrug therapy mediated by extracellular vesicles

    Article • Neoplasma, January 2023, AEPress, s.r.o.

    Cestmir Altaner

  4. Low-Dose-Rate Radiation-Induced Secretion of TGF-β3 Together with an Activator in Small Extracellular Vesicles Modifies Low-Dose Hyper-Radiosensitivity through ALK1 Binding

    Article • International Journal of Molecular Sciences, July 2022, MDPI AG

    Cestmir Altaner

  5. Gene-Directed Enzyme/Prodrug Therapy of Rat Brain Tumor Mediated by Human Mesenchymal Stem Cell Suicide Gene Extracellular Vesicles In Vitro and In Vivo

    Article • Cancers, January 2022, MDPI AG

    Cestmir Altaner

  6. Suicide Gene Therapy Mediated with Exosomes Produced by Mesenchymal Stem/Stromal Cells Stably Transduced with HSV Thymidine Kinase

    Article • Cancers, April 2020, MDPI AG

    Cestmir Altaner

  7. Intracellular acting tumor cell-targeted chemotherapy by MSC-suicide gene exosomes

    Article • Oncotarget, September 2019, Impact Journals, LLC

    Cestmir Altaner

  8. Mesenchymal Stem Cell Exosome-Mediated Prodrug Gene Therapy for Cancer

    Article • December 2018, Springer Science + Business Media

    Cestmir Altaner

  9. Prodrug suicide gene therapy for cancer targeted intracellular by mesenchymal stem cell exosomes

    Article • International Journal of Cancer, September 2018, Wiley

    Cestmir Altaner

  10. Dental Mesenchymal Stem/Stromal Cells and Their Exosomes

    Article • Stem Cells International, January 2018, Hindawi Publishing Corporation

    Cestmir Altaner

  11. MSC iron oxide exosomes for cancer therapy

    Article • International Journal of Nanomedicine, October 2017, Dove Medical Press

    Cestmir Altaner, Melania Babincova

  12. Exosomes of human mesenchymal stem/stromal/medicinal signaling cells

    Article • Neoplasma, January 2017, AEPress, s.r.o.

    Cestmir Altaner

  13. Low-Dose-Rate Irradiation for 1 Hour Induces Protection Against Lethal Radiation Doses but Does Not Affect Life Span of DBA/2 Mice

    Article • Dose-Response, October 2016, SAGE Publications

    Cestmir Altaner

  14. Dental pulp mesenchymal stem/stromal cells labeled with iron sucrose release exosomes and cells applied intra-nasally migrate to intracerebral glioblastoma

    Article • Neoplasma, January 2016, AEPress, s.r.o.

    Cestmir Altaner

  15. Prodrug Gene Therapy for Cancer Mediated by Mesenchymal Stem/Stromal Cells Engineered to Express Yeast Cytosinedeaminase::Uracilphos phoribosyltransferase

    Article • Journal of Stem Cell Research & Therapy, January 2015, OMICS Publishing Group

    Cestmir Altaner

  16. TGF-B3 Dependent Modification of Radiosensitivity in Reporter Cells Exposed to Serum from Whole-Body Low Dose-Rate Irradiated Mice

    Article • Dose-Response, October 2014, SAGE Publications

    Cestmir Altaner

  17. Comparison of human mesenchymal stem cells derived from dental pulp, bone marrow, adipose tissue, and umbilical cord tissue by gene expression

    Article • Biomedical Papers, September 2014, Palacky University Olomouc

    Cestmir Altaner

  18. Mesenchymal stem cells expressing therapeutic genes induce autochthonous prostate tumour regression

    Article • European Journal of Cancer, September 2014, Elsevier

    Cestmir Altaner

  19. Complete regression of glioblastoma by mesenchymal stem cells mediated prodrug gene therapy simulating clinical therapeutic scenario

    Article • International Journal of Cancer, September 2013, Wiley

    Cestmir Altaner

  20. Characterization of Mesenchymal Stem Cells of “No-Options” Patients with Critical Limb Ischemia Treated by Autologous Bone Marrow Mononuclear Cells

    Article • PLoS ONE, September 2013, PLOS

    Cestmir Altaner

  21. No Difference in Intra-Arterial and Intramuscular Delivery of Autologous Bone Marrow Cells in Patients with Advanced Critical Limb Ischemia

    Article • Cell Transplantation, September 2012, SAGE Publications

    Cestmir Altaner

  22. Intra-arterial Autologous Bone Marrow Cell Transplantation in a Patient with Upper-extremity Critical Limb Ischemia

    Article • CardioVascular and Interventional Radiology, May 2012, Springer Science + Business Media

    Cestmir Altaner

  23. Stem cell based glioblastoma gene therapy

    Article • Neoplasma, January 2012, AEPress, s.r.o.

    Cestmir Altaner

  24. Human adipose tissue‐derived mesenchymal stem cells expressing yeast cytosinedeaminase::uracil phosphoribosyltransferase inhibit intracerebral rat glioblastoma

    Article • International Journal of Cancer, August 2011, Wiley

    Cestmir Altaner

  25. Stem Cell Based Cancer Gene Therapy

    Article • Molecular Pharmaceutics, July 2011, American Chemical Society (ACS)

    Cestmir Altaner

  26. AUTOLOGOUS BONE MARROW CELLS TRANSPLANTATION IN PATIENTS WITH ADVANCED CRITICAL LIMB ISCHEMIA: NO DIFFERENCE IN INTRA-ARTERIAL AND INTRAMUSCULAR APPLICATION

    Article • Journal of the American College of Cardiology, April 2011, Elsevier

    Cestmir Altaner

  27. HSV-tk expressing mesenchymal stem cells exert bystander effect on human glioblastoma cells

    Article • Cancer Letters, April 2010, Elsevier

    Cestmir Altaner

  28. Adipose Tissue–derived Mesenchymal Stem Cells Expressing Prodrug-converting Enzyme Inhibit Human Prostate Tumor Growth

    Article • Molecular Therapy, January 2010, Elsevier

    Cestmir Altaner

  29. Tumor cell behaviour modulation by mesenchymal stromal cells

    Article • Molecular Cancer, January 2010, Springer Science + Business Media

    Cestmir Altaner

  30. Genotoxic damage of human adipose-tissue derived mesenchymal stem cells triggers their terminal differentiation

    Article • Neoplasma, January 2009, AEPress, s.r.o.

    Cestmir Altaner

  31. Prodrug cancer gene therapy

    Article • Cancer Letters, November 2008, Elsevier

    Cestmir Altaner

  32. Cytosine deaminase expressing human mesenchymal stem cells mediated tumour regression in melanoma bearing mice

    Article • The Journal of Gene Medicine, August 2008, Wiley

    Cestmir Altaner

  33. <emphasis emphasistype="italic">In Vitro</emphasis> Analysis of Cisplatin Functionalized Magnetic Nanoparticles in Combined Cancer Chemotherapy and Electromagnetic Hyperthermia

    Article • IEEE Transactions on NanoBioscience, March 2008, Institute of Electrical & Electronics Engineers (IEEE)

    Cestmir Altaner

  34. Adipose Tissue–Derived Human Mesenchymal Stem Cells Mediated Prodrug Cancer Gene Therapy

    Article • Cancer Research, July 2007, American Association for Cancer Research (AACR)

    Cestmir Altaner

  35. Novel germline mutation in the transmembrane region of RET gene close to Cys634Ser mutation associated with MEN 2A syndrome

    Article • Journal of Molecular Medicine, December 2004, Springer Science + Business Media

    Cestmir Altaner

  36. Long-term infection with retroviral structural gene vector provides protection against bovine leukemia virus disease in rabbits

    Article • Virology, November 2004, Elsevier

    Cestmir Altaner

  37. In vivoheating of magnetic nanoparticles in alternating magnetic field

    Article • Medical Physics, July 2004, Wiley

    Cestmir Altaner

  38. AC-magnetic field controlled drug release from magnetoliposomes: design of a method for site-specific chemotherapy

    Article • Bioelectrochemistry, January 2002, Elsevier

    Cestmir Altaner

  39. The human homologue of the bovine leukemia virus receptor BLVRcp1 is the δ-subunit of adaptor-related AP-3 protein that does not bind the BVLgp51

    Article • Archives of Virology, October 1999, Springer Science + Business Media

    Cestmir Altaner

  40. Temperature-Dependent Non-specific Adsorption of Recombinant Bovine Leukemia Virus Receptor BLVRcp1 in Immunoassay

    Article • Journal of Immunoassay, May 1997, Taylor & Francis

    Cestmir Altaner

  41. Isolation of the missing 5?-end of the encoding region of the bovine leukemia virus cell receptor gene

    Article • Archives of Virology, September 1994, Springer Science + Business Media

    Cestmir Altaner

  42. Envelope glycoprotein gp51 of bovine leukemia virus is differently glycosylated in cells of various species and organ origin

    Article • Veterinary Immunology and Immunopathology, March 1993, Elsevier

    Cestmir Altaner

  43. Mapping of sequential epitopes recognized by monoclonal antibodies on the bovine leukaemia virus external glycoproteins expressed in Escherichia coli by means of antipeptide antibodies

    Article • Journal of General Virology, September 1992, Society for General Microbiology

    Cestmir Altaner

  44. Protective vaccination against bovine leukaemia virus infection by means of cell-derived vaccine

    Article • Vaccine, December 1991, Elsevier

    Cestmir Altaner

  45. Use of monoclonal antibodies in an ELISA for the diagnosis of bovine leukaemia virus infection

    Article • Journal of Virological Methods, October 1990, Elsevier

    Cestmir Altaner

  46. Induction of immune deficiency syndrome in rabbits by bovine leukaemia virus

    Article • AIDS, November 1989, Wolters Kluwer Health

    Cestmir Altaner

  47. Infection of Rats with Bovine Leukaemia Virus: Establishment of a Virus-producing Rat Cell Line

    Article • Journal of General Virology, July 1989, Society for General Microbiology

    Cestmir Altaner

  48. Modifications of hybridoma technology which improve the yield of monoclonal antibody producing cells

    Article • Journal of Immunological Methods, November 1988, Elsevier

    Cestmir Altaner

  49. Cell‐Derived Vaccine Against Bovine Leukaemia Virus Infection

    Article • Journal of Veterinary Medicine Series B, January 1988, Wiley

    Cestmir Altaner

  50. Infectivity of avian myelocytomatosis virus in rats: Characterization of sera from infected rats

    Article • European Journal of Cancer and Clinical Oncology, November 1985, Elsevier

    Cestmir Altaner

  51. Isolation and characterization of cell clones producing various amounts of bovine leukosis virus

    Article • European Journal of Cancer and Clinical Oncology, November 1985, Elsevier

    Cestmir Altaner

  52. Study of expression of BLV genes in bacteria and in mammalian cells using recombinant vectors

    Article • European Journal of Cancer and Clinical Oncology, November 1985, Elsevier

    Cestmir Altaner

  53. Study of transfection of BLV containing DNA into NIH/3T3 cells

    Article • European Journal of Cancer and Clinical Oncology, November 1985, Elsevier

    Cestmir Altaner

  54. Role of 3′‐end of viral genome in tumor heteroinduction by the avian sarcoma virus

    Article • International Journal of Cancer, August 1982, Wiley

    Cestmir Altaner

  55. Suppression of the Avian Sarcoma Virus Genome in 8-Azaguanine-Resistant, Transformed, Hamster Cells1

    Article • JNCI Journal of the National Cancer Institute, August 1976, Oxford University Press (OUP)

    Cestmir Altaner

  56. Suppression of the Avian Sarcoma Virus Genome in Hamster-Transformed Cells Made Resistant to 8-Azaguanine

    Article • JNCI Journal of the National Cancer Institute, November 1974, Oxford University Press (OUP)

    Cestmir Altaner

  57. A Transmissible Antigen Detected in Two Cell Lines Derived from Human Tumours

    Article • Journal of General Virology, August 1974, Society for General Microbiology

    Cestmir Altaner

  58. Avian sarcoma virus transformed hamster cells resistant to bromodeoxyuridine and deficient in thymidine kinase activity

    Article • Archives of Virology, March 1973, Springer Science + Business Media

    Cestmir Altaner

  59. Carcinogenesis by RNA sarcoma viruses

    Article • Virology, January 1970, Elsevier

    Cestmir Altaner

  60. The effect of the ethyl hydrazide of podophyllic acid (SP I Sandoz) on proteosynthests of normal and tumour tissues in vivo

    Article • Biochemical Pharmacology, December 1966, Elsevier

    Cestmir Altaner